George W. Hardy

1.2k citations

27 papers · 924 indexed · 1 hit paper · h-index 14

Molecular Biology
Materials Chemistry
Organic Chemistry top 10%
Cellular and Molecular Neuroscience top 10%
Physiology

Co-authors: M. J. Merrett A.W. Phillips R. Haser L. A. LOWE Shahnaz Rahim T.W. Smith Richard Walker Paul L. Coe
Topics: Neuropeptides and Animal Physiology (6 papers)Chemical Synthesis and Analysis (4 papers)Biochemical and Molecular Research (4 papers)
Cited by: Molecular Biology Cellular and Molecular Neuroscience Biochemistry
Journals: Nature Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United Kingdom United States Japan

In The Last Decade

George W. Hardy

27 papers receiving 865 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sequence, structure and activity of phosphoglycerate kinase: a possible hinge-bending enzyme

1979 409 citations R. Haser, George W. Hardy et al. Nature profile →

Peers

Countries citing papers authored by George W. Hardy

Since Specialization

Citations

This map shows the geographic impact of George W. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George W. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George W. Hardy more than expected).

Fields of papers citing papers by George W. Hardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George W. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George W. Hardy. The network helps show where George W. Hardy may publish in the future.

Co-authorship network of co-authors of George W. Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of George W. Hardy. A scholar is included among the top collaborators of George W. Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George W. Hardy. George W. Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Highly tractable, sub-nanomolar non-steroidal glucocorticoid receptor agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Keith Biggadike,Matilde Caivano,(unknown),Diane M. Coe,George W. Hardy,(unknown),Haydn T. Jones,David House,(unknown),Philip A. Skone,Iain Uings,(unknown),Iain M. McLay,Simon J. F. Macdonald	8
2	Efficient synthesis of an α-trifluoromethyl-α-tosyloxymethyl epoxide enabling stepwise double functionalisation to afford CF3-substituted tertiary alcohols 2008 ·Tetrahedron Letters ·(unknown),Ian B. Campbell,Diane M. Coe,(unknown),George W. Hardy,(unknown),Haydn T. Jones,(unknown),(unknown),Philip A. Skone,Peter W. Sutton,(unknown),Simon J. F. Macdonald	8
3	Non-steroidal glucocorticoid agonists—The discovery of aryl pyrazoles as A-ring mimetics 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Diane M. Coe,(unknown),George W. Hardy,(unknown),Graham G. A. Inglis,Michael J. Johnston,Haydn T. Jones,David House,(unknown),(unknown),Philip A. Skone,Iain Uings,Iain M. McLay,Simon J. F. Macdonald	22
4	Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease 2002 ·Bioorganic & Medicinal Chemistry Letters ·Martin J. Slater,David Andrews,(unknown),(unknown),(unknown),(unknown),Berwyn Clarke,(unknown),(unknown),Andrew C. Good,Norman M. Gray,George W. Hardy,Paul S. Jones,(unknown),(unknown)	13
5	Discovery of Further Pyrrolidine trans-Lactams as Inhibitors of Human Neutrophil Elastase (HNE) with Potential as Development Candidates and the Crystal Structure of HNE Complexed with an Inhibitor (GW475151) 2002 ·Journal of Medicinal Chemistry ·Simon J. F. Macdonald,Michael D. Dowle,Lee A. Harrison,Geoffrey D. Clarke,Graham G. A. Inglis,Martin R. Johnson,Pritom Shah,Robin A.J. Smith,Augustin Amour,(unknown),(unknown),(unknown),(unknown),(unknown),Alan J. Wonacott,Onkar Singh,Simon T. Hodgson,George W. Hardy	48
6	Synthesis of tetrasubstituted bicyclo[3.2.1]octenes as potential inhibitors of influenza virus sialidase 1999 ·Bioorganic & Medicinal Chemistry Letters ·Paul S. Jones,Paul W. Smith,George W. Hardy,Peter D. Howes,Richard J. Upton,Richard C. Bethell	8
7	Efficient Syntheses of ( E )-5-(2-Bromovinyl)-2′-deoxy-4-thiouridine; A Nucleoside Analogue with Potent Biological Activity 1998 ·Nucleosides and Nucleotides ·(unknown),(unknown),(unknown),Nigel Westwood,(unknown),George W. Hardy,(unknown),Shahnaz Rahim,Richard Walker	6
8	Notes and Comments 1997 ·Journal of Energy & Natural Resources Law ·George W. Hardy	1
9	Acyl carbamate directing groups in nucleoside synthesis: Applications in the synthesis of 2′-deoxy-5-ethyl-4′-thiouridine 1996 ·Tetrahedron Letters ·(unknown),(unknown),Mark J. Robertson,(unknown),George W. Hardy,Robert J. Young	11
10	β-Anomer selectivity in 2′-deoxynucleoside synthesis: A novel approach using an acyl carbamate directing group 1994 ·Tetrahedron Letters ·Robert J. Young,(unknown),George W. Hardy,(unknown)	22
11	Peripherally acting enkephalin analogs. 2. Polar tri- and tetrapeptides 1989 ·Journal of Medicinal Chemistry ·George W. Hardy,L. A. LOWE,(unknown),(unknown),(unknown),R.L. Follenfant,(unknown),T.W. Smith	17
12	Antinociceptive effects of the novel opioid peptide BW443C compared with classical opiates; peripheral versus central actions 1988 ·British Journal of Pharmacology ·R.L. Follenfant,George W. Hardy,L. A. LOWE,C Schneider,T.W. Smith	30
13	Peripherally acting enkephalin analogs. 1. Polar pentapeptides 1988 ·Journal of Medicinal Chemistry ·George W. Hardy,L. A. LOWE,(unknown),(unknown),Samuel T. Wilkinson,R.L. Follenfant,T.W. Smith	15
14	A hybrid gene to express protein epitopes from both sporozoite and merozoite surface antigens of Plasmodium falciparum 1988 ·Parasitology ·Anthony A. Holder,M. Lockyer,George W. Hardy	13
15	Preclinical Pharmacology of a Novel Dual Acting Angiotensin Converting Enzyme Inhibitor with β‐Adrenoceptor Blocking Properties 1988 ·Cardiovascular Drug Reviews ·Geoffrey Allan,D. Cambridge,(unknown),George W. Hardy	1
16	BW A575C, a chemically novel agent with angiotensin converting enzyme inhibitor and β‐adrenoceptor‐blocking properties 1987 ·British Journal of Pharmacology ·G. Allan,D. Cambridge,George W. Hardy,(unknown)	12
17	Sequence, structure and activity of phosphoglycerate kinase: a possible hinge-bending enzymebreakdown → 1979 ·Nature ·(unknown),(unknown),(unknown),R. Haser,(unknown),George W. Hardy,M. J. Merrett,A.W. Phillips	409
18	Amino-acids and peptides. Part 42. Synthesis of a protected docosa peptide having the sequence of mast-cell degranulating peptide 1979 ·Journal of the Chemical Society Perkin Transactions 1 ·(unknown),(unknown),Richard P. Gregson,George W. Hardy,G. T. Young	6
19	Structural requirements for opioid activity of analogues of the enkephalins 1977 ·Proceedings of the Royal Society of London. Series B, Biological sciences ·C.R. Beddell,Robert B. Clark,George W. Hardy,L. A. LOWE,F. B. Ubatuba,John R. Vane,Stephen Wilkinson,Kwen‐Jen Chang,Pedro Cuatrecasas,R. J. Miller	77
20	Those stormy years : memories of the fight for freedom on five continents 1956 ·George W. Hardy	7

About George W. Hardy

George W. Hardy is a scholar working on Cellular and Molecular Neuroscience, Organic Chemistry and Biochemistry, having authored 27 papers that have together received 924 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (6 papers), Chemical Synthesis and Analysis (4 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Molecular Biology (646 citations), Cellular and Molecular Neuroscience (130 citations) and Biochemistry (49 citations). George W. Hardy has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include M. J. Merrett, A.W. Phillips, R. Haser, L. A. LOWE, Shahnaz Rahim, T.W. Smith, Richard Walker, Paul L. Coe, R.L. Follenfant and Robert B. Clark. Their work appears in journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact